Status:
TERMINATED
Study to Evaluate if Neoadjuvant Radiotherapy Improves Recurrence Free Survival in Pancreatic Head Cancer
Lead Sponsor:
CHIR-Net
Collaborating Sponsors:
Technical University of Munich
Conditions:
Pancreatic Adenocarcinoma
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Net-Pac investigates if radiation prior to surgical resection improves survival in patients with pancreatic head cancer without metastases.
Detailed Description
The trial is designed to show that neoadjuvant radiotherapy followed by surgery improves local recurrence free survival compared to surgery alone in patients with resectable adenocarcinoma of the panc...
Eligibility Criteria
Inclusion
- Histologically confirmed adenocarcinoma of the pancreatic head
- Age ≥ 18 years
- Signed informed consent
- ECOG performance status of 0-2
Exclusion
- Curative resection is not feasible or presence of metastatic disease
- Patients not eligible for surgery (ASA ≥ 4)
- Participation in an other clinical trial
- Unable or unwilling to sign the informed consent
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT01419002
Start Date
October 1 2011
End Date
October 1 2014
Last Update
July 29 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinikum rechts der Isar, Technische Universität München
Munich, Germany, 81675